Antiretroviral therapy response among HIV-2 infected patients: a systematic review (Q27003854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

6

Geoffrey S Gottlieb

Geoffrey S

Gottlieb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

7

Marco Vitoria

Marco

Vitoria

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

9

Serge P Eholie

Serge P

Eholie

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1

Didier K Ekouevi

Didier K

Ekouevi

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

4

Joseph Tegbe

Joseph

Tegbe

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Patrick Ahuatchi Coffie

3

Patrick A Coffie

Patrick A

Coffie

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

8

François Dabis

François

Dabis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

Alexandra M Bitty-Anderson

5 June 2020

5

Alexandra M Anderson

Alexandra M

Anderson

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

1 reference

26 August 2014

8 references

23 March 2019

22 June 2019

19 October 2019

3 November 2019

1 July 2020

25 October 2022

10 January 2024

BMC Infectious Diseases

9 references

23 March 2019

22 June 2019

19 October 2019

3 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 July 2020

25 October 2022

10 January 2024

14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1

0 references

page(s)

461

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

5 June 2020

copyright license

7 references

23 March 2019

22 June 2019

19 October 2019

3 November 2019

1 July 2020

25 October 2022

10 January 2024

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Genotypic resistance profiles of HIV-2-treated patients in West Africa

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Highly active antiretroviral therapy and viral response in HIV type 2 infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

British HIV Association guidelines for antiretroviral treatment of HIV‐2‐positive individuals 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-461

Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4156654

[Efficacy and tolerance of antiretroviral therapy in HIV-2 infected patients in Dakar: preliminary study]

28 November 2018

1 reference

12 December 2020

Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection

1 reference

12 December 2020

Commentary: decline of HIV-2 prevalence in West Africa: good news or bad news?

1 reference

12 December 2020

HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-14-461

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 June 2020

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154616%20AND%20SRC:MED&resulttype=core&format=json